Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D08DWM | ||||
| Former ID | DIB000597 | ||||
| Drug Name | Gp100:209-217(210M) peptide vaccine | ||||
| Synonyms | Gp100 melanoma-associated antigen vaccine, NCI; Gp100:209-217(210M) peptide vaccine (melanoma); Gp100:209-217(210M) peptide vaccine (melanoma), NCI | ||||
| Drug Type | Vaccine | ||||
| Indication | Melanoma [ICD9: 172; ICD10:C43] | Phase 2 | [521456] | ||
| Company | National Cancer Institute | ||||
| Target and Pathway | |||||
| Target(s) | Melanocytes lineage-specific antigen GP100 | Target Info | [550405] | ||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
